Work

610 Efficacy and Safety of Benralizumab in Adults and Adolescents With Eosinophilic Esophagitis: Results From the 24-week Double-blind Period of the Phase 3 Messina Trial

Year: 2023

Type: article

Source: Gastroenterology

DOI: 10.1016/s0016-5085(23)01239-8

Authors: Marc E. Rothenberg, Evan S. Dellon, Margaret H. Collins, Albert J. Bredenoord, Ikuo Hirano, Kathryn A. Peterson, Laura Brooks, Harald Fjallbrant, Hanna K. Grindebacke, Calvin N. Ho, Matthew Keith, Christopher McCrae, Wendy White, Catherine Datto

Language: English

Topic: Eosinophilic Esophagitis

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4383420198

FWCI: 3.279

Cites:

Cited by: 13

Related to: 10